Symmetric Gets Growth Investment From Spectrum Equity

A hospital can own advanced clinical systems and still depend on a product catalog that changes every day. When that catalog is wrong, the failure can travel from purchasing into the operating room, a reimbursement claim, a recall response, or the search for a substitute during a shortage.

Symmetric Health Solutions has spent 8 years building the data layer beneath those decisions. On October 6, 2026, the Pittsburgh healthcare technology company announced an undisclosed strategic growth investment from Spectrum Equity, its first institutional capital since Rich Kucera, Tomás (TJ) Dardet Preston, Jon Boerner, and Ryan Kissell founded the business in 2018.

The investment gives a profitable, bootstrapped company room to expand its product roadmap, go-to-market team, customer-success organization, and hiring. It also puts growth capital behind a basic operating truth in healthcare: artificial intelligence, resiliency planning, purchasing automation, and revenue integrity all become unreliable when the product record underneath them cannot be trusted.

What Happened

Spectrum Equity made a strategic growth investment in Symmetric after the company spent 8 years growing without institutional backing. The firms did not disclose the investment amount, valuation, ownership percentage, board terms, or other transaction economics, so the announcement should be understood as an undisclosed growth investment rather than a priced venture round.

Symmetric says it has remained profitable since founding. Kucera and Dardet Preston encountered hospital supply-chain data problems while working as consultants at Accenture, then joined fellow Carnegie Mellon alumni Boerner and Kissell to build a company around the issue. Kucera serves as co-founder and CEO, while the current Symmetric leadership page places Dardet Preston in solutions, Kissell in operations, and Boerner in product leadership.

Latham & Watkins separately confirmed that it advised Spectrum on the transaction. No other investor was disclosed.

Why Hospital Item Data Matters

A hospital item master can contain more than 500,000 rows, with each record representing a product the organization may purchase, stock, scan, bill, substitute, or recall. Those records can include identification numbers, packaging details, manufacturer and supplier relationships, reimbursement codes, product classifications, clinical attributes, pricing terms, and contract data.

The catalog does not stay still. Spectrum says roughly 30% of a hospital's item master can turn over in a year as products launch, packaging changes, manufacturers update catalogs, reimbursement codes move, and contracts accumulate amendments. Manufacturers, distributors, group purchasing organizations, and hospitals may each describe the same product differently, leaving operating teams to reconcile records by hand.

The cost of that mismatch is practical. An implant can be used without the billing code required for reimbursement. Duplicate item numbers can fragment purchase volume and hide earned pricing tiers. A recalled device can remain in inventory because the notice does not map cleanly to the hospital's record. During a shortage, a sourcing team may struggle to identify a clinically acceptable substitute.

How Symmetric Built Its Data Layer

Symmetric reconciles data from regulatory registries, manufacturer catalogs, GPO contracts, and hundreds of other sources into maintained product records. The platform covers identifiers and classifications including GTIN, UDI, UNSPSC, HCPCS, and GMDN, alongside packaging, supplier lineage, clinical descriptors, country-of-origin data, tariff information, and substitute relationships.

The company says its database contains nearly 20 million healthcare items, up to 1,800 attributes per item, and 5 million verified substitutes. More than 45 health systems contribute verification, according to the investment announcement, while Symmetric reports a 96% average match rate and 98% customer retention since founding. Symmetric's website separately says its data supports more than 1,200 hospitals. These are company and investor-reported metrics rather than independently audited figures.

Symmetric pushes maintained data into hospital systems through integrations with Workday, Oracle, and Infor. That placement matters because the product is designed to improve the record used by existing workflows, not force every supply-chain, finance, and clinical team to adopt another isolated interface.

What Spectrum Equity Is Backing

Spectrum's investment thesis reaches beyond a one-time data-cleansing project. Static cleanup decays as products, contracts, codes, suppliers, and packaging keep changing. Symmetric is selling continuous maintenance and a shared product identity that can remain useful across procurement, value analysis, finance, clinical operations, revenue cycle, and resiliency planning.

The company plans to expand go-to-market and customer success while advancing products built on that data foundation. Its Contract Management product is already used by more than one in five customers, according to the announcement. The roadmap also includes a supply-chain control tower, revenue-integrity tools, value-analysis capabilities, and a supplier portal, while Symmetric's current careers page lists openings across implementation, customer success, product support, engineering, and people operations.

For Spectrum, the attraction is a vertical data business embedded in workflows that carry financial and clinical consequences. The firm has previously invested across healthcare software and data companies, and managing director Michael Radonich described trustworthy supply-chain data as the prerequisite for applying AI to healthcare operations.

What This Changes

Healthcare organizations are being asked to forecast shortages, automate procurement, improve charge capture, reduce clinical variation, and deploy AI without losing control of the underlying evidence. Each ambition increases the value of a reliable item record, because the automation will inherit every ambiguity in the data it receives.

Symmetric now has capital to expand a system customers already depend on, but the obligation grows with the opportunity. More hospitals, products, contracts, and automated decisions will test whether the company can preserve its reported match quality and customer trust while broadening the platform. The next stage will be measured in how often an accurate record prevents an operating problem before the hospital has to discover it through a missed payment, an unavailable product, or a device that should have left the shelf sooner.